124 related articles for article (PubMed ID: 6620016)
1. Primary gonadal damage following treatment of brain tumors in childhood.
Ahmed SR; Shalet SM; Campbell RH; Deakin DP
J Pediatr; 1983 Oct; 103(4):562-5. PubMed ID: 6620016
[TBL] [Abstract][Full Text] [Related]
2. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
3. Gonadal function after bone marrow transplantation for acute leukemia during childhood.
Sarafoglou K; Boulad F; Gillio A; Sklar C
J Pediatr; 1997 Feb; 130(2):210-6. PubMed ID: 9042122
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma: clinical and biologic aspects.
Packer RJ; Cogen P; Vezina G; Rorke LB
Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
[TBL] [Abstract][Full Text] [Related]
5. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
6. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
[TBL] [Abstract][Full Text] [Related]
7. Ovarian function following chemotherapy for childhood brain tumours.
Clayton PE; Shalet SM; Price DA; Jones PH
Med Pediatr Oncol; 1989; 17(2):92-6. PubMed ID: 2704342
[TBL] [Abstract][Full Text] [Related]
8. The effects of adjuvant chemotherapy on growth in children with medulloblastoma.
Olshan JS; Gubernick J; Packer RJ; D'Angio GJ; Goldwein JW; Willi SM; Moshang T
Cancer; 1992 Oct; 70(7):2013-7. PubMed ID: 1525779
[TBL] [Abstract][Full Text] [Related]
9. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.
Evans AE; Jenkin RD; Sposto R; Ortega JA; Wilson CB; Wara W; Ertel IJ; Kramer S; Chang CH; Leikin SL
J Neurosurg; 1990 Apr; 72(4):572-82. PubMed ID: 2319316
[TBL] [Abstract][Full Text] [Related]
10. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study.
Krischer JP; Ragab AH; Kun L; Kim TH; Laurent JP; Boyett JM; Cornell CJ; Link M; Luthy AR; Camitta B
J Neurosurg; 1991 Jun; 74(6):905-9. PubMed ID: 2033450
[TBL] [Abstract][Full Text] [Related]
11. Neurobehavioral and neurologic outcome in long-term survivors of posterior fossa brain tumors: role of age and perioperative factors.
Chapman CA; Waber DP; Bernstein JH; Pomeroy SL; LaVally B; Sallan SE; Tarbell N
J Child Neurol; 1995 May; 10(3):209-12. PubMed ID: 7642890
[TBL] [Abstract][Full Text] [Related]
12. Growth and endocrine function after treatment for medulloblastoma.
Brown IH; Lee TJ; Eden OB; Bullimore JA; Savage DC
Arch Dis Child; 1983 Sep; 58(9):722-7. PubMed ID: 6414386
[TBL] [Abstract][Full Text] [Related]
13. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
14. [Role of adjuvant chemotherapy in the treatment of medulloblastoma in children].
Sachivko NV; Konoplia NE; Petrovich SV; Sharak EV
Vopr Onkol; 2002; 48(3):318-21. PubMed ID: 12455354
[TBL] [Abstract][Full Text] [Related]
15. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
[TBL] [Abstract][Full Text] [Related]
16. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I).
Tait DM; Thornton-Jones H; Bloom HJ; Lemerle J; Morris-Jones P
Eur J Cancer; 1990 Apr; 26(4):464-9. PubMed ID: 2141512
[TBL] [Abstract][Full Text] [Related]
18. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
[TBL] [Abstract][Full Text] [Related]
19. Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy.
Rutkauskiene G; Labanauskas L
Medicina (Kaunas); 2005; 41(12):1026-34. PubMed ID: 16401959
[TBL] [Abstract][Full Text] [Related]
20. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies.
Constine LS; Rubin P; Woolf PD; Doane K; Lush CM
J Clin Oncol; 1987 Nov; 5(11):1841-51. PubMed ID: 3681371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
